Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:1288-1295
Published online before print April 6, 2006, doi: 10.1161/01.STR.0000217389.55009.f8
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/5/1288    most recent
01.STR.0000217389.55009.f8v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martín, A.
Right arrow Articles by Planas, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martín, A.
Right arrow Articles by Planas, A. M.
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction

(Stroke. 2006;37:1288.)
© 2006 American Heart Association, Inc.


Original Contributions

Why Does Acute Hyperglycemia Worsen the Outcome of Transient Focal Cerebral Ischemia?

Role of Corticosteroids, Inflammation, and Protein O-Glycosylation

Abraham Martín, MSc; Santiago Rojas, MSc; Ángel Chamorro, MD, PhD; Carles Falcón, PhD; Núria Bargalló, MD, PhD Anna M. Planas, PhD

From the Department of Pharmacology and Toxicology (A.M., S.R., A.M.P.), Institut d’Investigacions Biomèdiques de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; the Stroke Unit (A.C.), Institut de Malalties del Sistema Nerviós (IMSN), Hospital Clínic, IDIBAPS, Barcelona, Spain; the IDIBAPS (C.F.); Barcelona, Spain; the Servei de Diagnòstic per la Imatge (N.B.), Hospital Clínic, Barcelona, Spain.

Correspondence to Anna M. Planas, PhD, Department of Pharmacology and Toxicology, IIBB-CSIC, IDIBAPS, Rosselló 161, E-08036-Barcelona, Spain. E-mail ampfat{at}iibb.csic.es

Background and Purpose— Hyperglycemia adversely affects the outcome of stroke. Global ischemia data support that the harmful effect of hyperglycemia is mediated by glucose-induced elevated plasma glucocorticoids. Here we sought to evaluate the negative effects of hyperglycemia on transient focal ischemia in the rat, and to test whether these could be prevented by inhibition of either corticosteroid production or neutrophil infiltration.

Methods— Sprague-Dawley rats (n=217) were used. Ischemia was induced by 1 hour middle cerebral artery occlusion (n=196). Acute hyperglycemia was induced by IP injection of dextrose 30 minutes before ischemia. Neutrophil infiltration was blocked by neutropenia with vinblastine. Corticosterone synthesis was inhibited by chemical adrenalectomy with metyrapone. We measured MRI lesion and tissue infarct volumes, evaluated the neurological function, brain myeloperoxidase and matrix metalloproteinase-9 activities, and protein O-glycosylation.

Results— Hyperglycemia significantly enhanced MRI diffusion-weighted imaging alterations, increased cortical, but not subcortical, infarct volume, worsened neurological score, and enhanced brain myeloperoxidase and matrix metalloproteinase-9 activities. Metyrapone did not prevent hyperglycemic brain damage despite successful reduction of plasma corticosterone. Yet, metyrapone tended to reduce cortical infarction and apparent diffusion coefficient lesion volume, indicating some negative contribution of corticosterone. Blocking neutrophil infiltration was also ineffective to prevent the harmful effect of hyperglycemia. A new finding was that O-linked glycosylation of cerebral proteins was increased under hyperglycemia.

Conclusions— In transient middle cerebral artery occlusion, the hyperglycemia-exacerbated brain damage cannot be fully explained by the negative effects of plasma corticosteroids or neutrophil infiltration. The contribution of other intrinsic effects of high glucose, such as brain protein O-glycosylation, deserves further investigation.


Key Words: brain infarction • corticosteroids • glucose • metalloproteinases • neutrophils • rats




This article has been cited by other articles:


Home page
StrokeHome page
K. Tsuda
Role of Hyperglycemia and Glutamate Receptors in Ischemic Injury in Acute Cerebral Infarction
Stroke, September 1, 2006; 37(9): 2199 - 2199.
[Full Text] [PDF]


Home page
StrokeHome page
A. Martin and A. M. Planas
Response to Letter by Tsuda
Stroke, September 1, 2006; 37(9): 2200 - 2200.
[Full Text] [PDF]